Thyroid stimulating hormone downregulates vascular endothelial growth factor expression in FRTL-5 cells

Thyroid. 2001 Jun;11(6):539-43. doi: 10.1089/105072501750302831.

Abstract

We studied the regulation of the expression of vascular endothelial growth factor (VEGF) by TSH in monolayer cultures of rat thyroid FRTL-5 cell lines. The VEGF mRNA synthesis was significantly inhibited by TSH as well as dibutyryl cyclic adenosine monophosphate (cAMP) in a dose-dependent manner in FRTL-5 cells. This observation is contrary to previously published results using the thyroid follicular culture system. Our results suggest that the direct effect of TSH/cAMP is to inhibit the VEGF synthesis in monolayer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bucladesine / pharmacology
  • Cell Line
  • Down-Regulation
  • Endothelial Growth Factors / genetics
  • Endothelial Growth Factors / metabolism*
  • Lymphokines / genetics
  • Lymphokines / metabolism*
  • RNA, Messenger / metabolism
  • Rats
  • Thyrotropin / pharmacology*
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Endothelial Growth Factors
  • Lymphokines
  • RNA, Messenger
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Bucladesine
  • Thyrotropin